Price $117.12 |
Market Cap
10.42B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
52.0
|
P/B
1.4
|
P/S
3.95
|
Dividend %
0.30%
|
|
P/CF
11.6
|
P/FCF
90.9
|
Op. Cash Flow
227.3K
|
FCF
0.9
|
|
Op. Margin
14.40%
|
Net Margin
29.30%
|
ROE
10.80%
|
ROI
5.10%
|
|
ROA
5.80%
|
EPS Growth
19.00%
|
Current Ratio
2.1
|
Debt/Equity
53.10%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| InMed Pharmaceuticals Inc (INM) | $0.27 | - | - | 1.6M | Strong Buy |
| Navidea Biopharmaceuticals Inc (NAVB) | $0.00 | - | - | 5M | Strong Buy |
| Owens & Minor, Inc. (OMI) | $15.72 | - | - | 1.19B | Strong Buy |
| PetIQ Inc (PETQ) | $30.58 | - | - | 564.3M | Strong Buy |
| Pharmacyte Biotech Inc (PMCB) | $1.65 | - | - | 18.9M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
